REQUEST A DEMO
Total
USD $0.00
Search more companies

Jainam Pharma (India) Private Limited (India)

Main Activities: All Other Chemical Product and Preparation Manufacturing
Full name: Jainam Pharma (India) Private Limited Profile Updated: January 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Jainam Pharma (india) Private Limited is an unlisted company, incorporated on 04/06/2010. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24297MH2010PTC203695 and registration number is 203695. The company is a trade company, it is engaged in retail trading.

Headquarters
905 Lodha Supremus Senapati Bapat Marg Opp Lodha World Towers Lower Parel (W) Mumbai In-Mh In 400013
Mumbai; Maharashtra; Postal Code: 400013

Contact Details: Purchase the Jainam Pharma (India) Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Jainam Pharma (India) Private Limited report to view the information.
Outstanding Shares:
Purchase the Jainam Pharma (India) Private Limited report to view the information.
Registered Capital:
Purchase the Jainam Pharma (India) Private Limited report to view the information.
Incorporation Date:
June 04, 2010
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
29.63%
Purchase this report to view the information.
24.91%
Company Performance
Financial values in the chart are available after Jainam Pharma (India) Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
62.96%
Total operating revenue
62.16%
Operating profit (EBIT)
45.06%
EBITDA
40.63%
Net Profit (Loss) for the Period
30.05%
Total assets
20.22%
Total equity
9.28%
Operating Profit Margin (ROS)
-0.16%
Net Profit Margin
-0.24%
Return on Equity (ROE)
1.36%
Debt to Equity Ratio
72.6%
Quick Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?